Combatting T-cell tumours with antibody drug conjugates
One treatment with the anti-TRBC1-SG3249 ADC combination saw cancer elimination…
One treatment with the anti-TRBC1-SG3249 ADC combination saw cancer elimination within seven days in mouse models.